Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India.
Paediatric Biochemistry Unit, Department of Paediatrics, Post Graduate Institute of Medical Education & Research, Chandigarh, India.
Clin Rheumatol. 2024 Aug;43(8):2607-2613. doi: 10.1007/s10067-024-07017-z. Epub 2024 Jun 13.
Takayasu arteritis (TA) is a chronic granulomatous inflammatory disease affecting the aorta and its branches. Paediatric TA (pTA) may present from 6 months after birth till the adolescent age group. Genetics and pathogenesis of pTA are not fully understood. Earlier studies reported monogenic mutation in NOD2, XIAP, and STAT1 genes in patients with pTA. TA, a relatively rare disease, is more common in geographical pockets, including India. We hypothesized that South Asian patients with pTA, namely, those of Indian subcontinent origin, may have clinically relevant and unique pathogenic variants involving one or more genes, especially those linked to genetically driven vasculitic illnesses, including autoinflammatory pathologies. Children with pTA fulfilling EULAR/PRINTO/PReS classification criteria and presenting with clinical symptoms to the Paediatric Rheumatology clinic of Christian Medical College, Vellore, were included. Blood samples were collected after getting informed consent from parents or guardians and assent forms from children. DNA was extracted from whole blood using the Qiagen DNA extraction kit. Initially, the common variant in Indian population, namely, ADA2 c.139G > A; p.Gly47Arg, was screened, followed by whole exome sequencing. Fourteen children were recruited for the study. Median age of patients was 11 years (4 months-14 years) with a male-to-female ratio of 4:10. Distribution of angiographic subsets by Numano's classification of included children were as follows: type 5 (n = 7), type 4 (n = 5), and type 3 (n = 2). We identified novel variants in ten different genes. This include variants in genes of classical complement pathway, namely, C2, C3, C6, C7, and C9, and other genes, namely, CYBA, SH3BP2, GUCY2C, CTC1, COL5A1, and NLPR3. Two of 14 patients have heterozygous pathogenic variants; this implies that combination of heterozygous variants in C3 and COL5A1 might lead to disease development, suggesting digenic inheritance. One patient has a homozygous variant in CYBA. None of the patients were identified to have ADA2 variants. Whole exome sequencing reveals combination of rare variants in genes C3, COL5A1, and CYBA associated with disease development in children with Takayasu Arteritis. Key Points • We identified novel variants in genes of classical complement pathway, namely, C2, C3, C6, C7, and C9, and other genes, namely, CYBA, SH3BP2, GUCY2C, CTC1, COL5A1, and NLPR3. • Two of 14 patients have heterozygous pathogenic variants in C3 and COL5A1; this may have implications in disease development, suggesting digenic inheritance. • One patient has homozygous variant in CYBA. • None of the patients were identified to have ADA2 variants.
Takayasu 动脉炎(TA)是一种影响主动脉及其分支的慢性肉芽肿性炎症性疾病。儿科 Takayasu 动脉炎(pTA)可在出生后 6 个月至青少年时期出现。pTA 的遗传学和发病机制尚未完全阐明。早期研究报道,NOD2、XIAP 和 STAT1 基因的单基因突变存在于 pTA 患者中。TA 是一种相对罕见的疾病,在包括印度在内的一些地区更为常见。我们假设南亚的 pTA 患者,即来自印度次大陆的患者,可能具有临床上相关且独特的致病性变异,涉及一个或多个基因,特别是那些与遗传驱动的血管炎疾病相关的基因,包括自身炎症性疾病。符合 EULAR/PRINTO/PReS 分类标准并出现临床症状的儿科患者在维洛尔基督教医学院儿科风湿病科就诊。在获得父母或监护人的知情同意书和儿童的同意书后,采集血样。使用 Qiagen DNA 提取试剂盒从全血中提取 DNA。最初,筛选了印度人群中的常见变异体,即 ADA2 c.139G > A;p.Gly47Arg,随后进行了全外显子组测序。本研究共纳入 14 名儿童。患者的中位年龄为 11 岁(4 个月至 14 岁),男女比例为 4:10。根据 Numano 的分类,包括儿童的血管造影亚组分布如下:5 型(n=7)、4 型(n=5)和 3 型(n=2)。我们在 10 个不同的基因中发现了新的变异体。这包括经典补体途径的基因 C2、C3、C6、C7 和 C9 的变异体,以及其他基因 CYBA、SH3BP2、GUCY2C、CTC1、COL5A1 和 NLPR3 的变异体。14 名患者中有 2 名存在杂合致病性变异体;这意味着 C3 和 COL5A1 中的杂合变异体的组合可能导致疾病的发生,提示双基因遗传。1 名患者的 CYBA 存在纯合变异体。没有患者被发现有 ADA2 变异体。全外显子组测序揭示了 C3、COL5A1 和 CYBA 基因中的罕见变异体组合与 Takayasu 动脉炎患儿的疾病发展有关。要点:
我们在经典补体途径的基因 C2、C3、C6、C7 和 C9 以及其他基因 CYBA、SH3BP2、GUCY2C、CTC1、COL5A1 和 NLPR3 中发现了新的变异体。
14 名患者中有 2 名存在 C3 和 COL5A1 的杂合致病性变异体;这可能对疾病的发展有影响,提示双基因遗传。
1 名患者的 CYBA 存在纯合变异体。
没有患者被发现有 ADA2 变异体。